Asia-Pacific digital pathology Market

Asia-Pacific digital pathology Market Size, Share & Trends Analysis Report by Products and Services (Diagnostic Devices, Scanners and Microscope, Communication Platform, Storage, and Others), by End-User (Biotechnology and Pharmaceutical Companies, Diagnostic Centers, and Academics Centers), by Applications (Anatomical Pathology, Chemical Pathology, Forensic Pathology, Clinical Pathology, Immunopathology Pathology, and Others) Forecast Period 2019-2025
    Update Available - Forecast 2024-2030   

Published: Feb 2020 | Report Code: OMR2021019 | Category : Medical Devices | Delivery Format: /

Asia-Pacific digital pathology market is growing at a CAGR of approximately 19.6% during the forecast period. Asia- Pacific region is expected to grow at fast rate in the digital pathology market due to increasing healthcare spending, demand for efficient and cost-effective equipment and development in healthcare infrastructure. The population of APAC region is expected to reach at 3.7 billion by 2025. The increase in population will increase the demand for healthcare systems throughout the region, and enhance the Asia-Pacific digital pathology. The unmet demand of healthcare systems will create opportunity for adoption digital healthcare application & EHR. Additionally, the evolutionary change in APAC eHealth sector is due to increasing trend of telehealth and mobile Health. 

Visit for Global Digital Pathology Market Report at: https://www.omrglobal.com/industry-reports/digital-pathology-market

Although disease patterns change constantly, communicable diseases are one of the leading causes of mortality in the Asia-Pacific countries. Despite decades of economic growth and development in South East Asia Region, most countries in this region still have a high burden of non- communicable diseases (NCD). These diseases are mainly cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases are on top of the list in the South-East Asia region, claiming an estimated of more than 8.5 million lives each year. 62% of all deaths occur due to non-communicable diseases in the region, and 48% of all mortalities occurring from NCDs attack people.

The major noncommunicable diseases are due to modifiable behavioral risk factors include unhealthy diet, tobacco use, alcohol, and insufficient physical activity. Demographic trends such as urbanization, population ageing, and better-quality healthcare demand, contribute to the expansion of the market. Furthermore, the penetration of medical devices such as digital pathology and point of care devices into South Asian countries is relatively low, thus there is much room for growth and expansion of the Asia-Pacific digital pathology market. The authority of countries allows medical devices companies to adopt different market strategies and provide ample opportunities for device segmentation. Hence, the Asia-Pacific digital pathology market is expected to grow in the near future. 

Research Methodology

The market study of the Asia-Pacific digital pathology market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for digital pathology software, service and devices manufacturers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Asia-Pacific Digital Pathology Market Research and Analysis by Product and Services

2. Asia-Pacific Digital Pathology Market Research and Analysis by End-user

3. Asia-Pacific Digital Pathology Market Research and Analysis by Application

The Report Covers

  • Comprehensive research methodology of the Asia-Pacific Digital Pathology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific Digital Pathology market.
  • Insights about market determinants which are stimulating the Asia-Pacific Digital Pathology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Asia-Pacific Digital Pathology Market by Products and Services

5.1.1. Diagnostic Devices

5.1.2. Scanners and Microscope

5.1.3. Communication Platform

5.1.4. Storage

5.1.5. Others

5.2. Asia-Pacific Digital pathology Market by End-User

5.2.1. Biotechnology and Pharmaceutical Companies

5.2.2. Diagnostic Centers

5.2.3. Academics Centers

5.3. Asia-Pacific Digital Pathology Market by Applications

5.3.1. Anatomical Pathology

5.3.2. Chemical Pathology

5.3.3. Forensic Pathology

5.3.4. Clinical Pathology

5.3.5. Immunopathology Pathology

5.3.6. Others

6. Regional Analysis

6.1. China

6.2. India

6.3. Japan

6.4. Rest of Asia-Pacific

7. Company Profiles

7.1. BARCO

7.2. Carl Zeiss AG

7.3. Leica Microsystems GmbH

7.4. Nikon Instruments Inc.

7.5. Olympus Corp.

7.6. Philips Healthcare

7.7. Sysmex Corp.

1. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCTS AND SERVICES, 2018-2025 ($ MILLION)

2. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

3. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

4. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)


1. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SHARE BY PRODUCTS AND SERVICES, 2018 VS 2025 (%)

2. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SHARE BY END-USER, 2018 VS 2025 (%)

3. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

4. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

5. CHINA DIGITAL PATHOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

6. INDIA DIGITAL PATHOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

7. JAPAN DIGITAL PATHOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

8. REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, 2018-2025 ($ MILLION)